M. Ardelt

PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling

M. Kwiatkowski, H. Schlüter, K. Rudolph, 2022, Nature Communications.

Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.

S. Zahler, A. Vollmar, T. Lehr, 2014, Journal of hepatology.

Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMT

S. Zahler, A. Vollmar, D. Lamb, 2017, Molecular Cancer Therapeutics.

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

M. Raderer, C. Pirich, W. Hitzl, 2020, International journal of endocrinology.

The long non-coding RNA H19 - a new player in hepatocellular carcinoma

J. Pachmayr, M. Ardelt, Johanna Pachmayr, 2017, Cell stress.

Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers

A. Vollmar, I. Jeremias, S. Sieber, 2021, Scientific Reports.

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

S. Zahler, A. Vollmar, T. Lehr, 2018, Hepatology.

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

A. Vollmar, H. Zischka, A. Gerbes, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma

K. Rudolph, K. Thedieck, A. Koeberle, 2020, Nature Communications.

Multi-feature clustering of CTCF binding creates robustness for loop extrusion blocking and Topologically Associating Domain boundaries

K. Rudolph, A. Papale, K. Thedieck, 2023, Nature communications.

Inhibition of Cyclin-dependent Kinase 5 – a Novel Strategy to Improve Sorafenib Response in HCC Therapy

Giorgio, S. Zahler, A. Vollmar, 2018 .